Back
FolioBeyond Alternative Income and Int Rt Hdg ETF Vs. Xenon Pharmaceuticals, Inc. Industry Stock Comparison
Sell
35
RISR
FolioBeyond Alternative Income and Int Rt Hdg ETF
Last Price:
$36.29
Seasonality Move:
4.06%
Buy
62
XENE
Xenon Pharmaceuticals, Inc.
Last Price:
$56.89
Seasonality Move:
4.19%
Sell
35
FolioBeyond Alternative Income and Int Rt Hdg ETF (RISR)
is a Sell
Is FolioBeyond Alternative Income and Int Rt Hdg ETF a Buy, Sell or Hold?
-
The current FolioBeyond Alternative Income and Int Rt Hdg ETF [RISR] share price is $36.25. The Score for RISR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
RISR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Xenon Pharmaceuticals, Inc. (XENE)
is a Buy
Is Xenon Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Xenon Pharmaceuticals, Inc. [XENE] share price is $56.85. The Score for XENE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
XENE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RISR Stock Price Chart
What is FolioBeyond Alternative Income and Int Rt Hdg ETF's stock price today?
-
The FolioBeyond Alternative Income and Int Rt Hdg ETF share price today is $36.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RISR is experiencing selling pressure, which indicates risk of future bearish movement.
XENE Stock Price Chart
What is Xenon Pharmaceuticals, Inc.'s stock price today?
-
The Xenon Pharmaceuticals, Inc. share price today is $56.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XENE is experiencing slight buying pressure.
RISR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 53.8 | Buy |
| Chaikin Money Flow: | -29969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.83 - 36.35) | Buy |
| Bollinger Bands (100): | (35.79 - 36.23) | Buy |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 61.55 | Buy |
| Chaikin Money Flow: | 226752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.95 - 59.27) | Buy |
| Bollinger Bands (100): | (39.35 - 50.85) | Buy |
RISR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.29 | Sell |
| 20-day SMA: | 36.19 | Buy |
| 50-day SMA: | 35.98 | Buy |
| 200-day SMA: | 36.24 | Buy |
| 8-day EMA: | 36.26 | Sell |
| 20-day EMA: | 36.18 | Buy |
| 50-day EMA: | 36.06 | Buy |
| 200-day EMA: | 36.11 | Buy |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.78 | Buy |
| 20-day SMA: | 55.66 | Buy |
| 50-day SMA: | 47.7 | Buy |
| 200-day SMA: | 40.77 | Buy |
| 8-day EMA: | 56.09 | Buy |
| 20-day EMA: | 54.07 | Buy |
| 50-day EMA: | 49.75 | Buy |
| 200-day EMA: | 42.9 | Buy |
FolioBeyond Alternative Income and Int Rt Hdg ETF Earnings Growth & RISR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xenon Pharmaceuticals, Inc. Earnings Growth & XENE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.55 per share, and an increase next year of $0.10 per share.
FolioBeyond Alternative Income and Int Rt Hdg ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||